Teyi Pharmaceutical Group (002728.SZ): Glucosamine sulfate capsules have obtained a drug registration certificate.
Tefi Pharmaceutical (002728.SZ) announced that its wholly-owned subsidiary, Hainan Haili Pharmaceutical Co., Ltd. (referred to as "Haili Pharmaceutical"), recently received the "Drug Registration Certificate" for glucosamine sulfate capsules issued by the National Medical Products Administration. Glucosamine sulfate capsules are used for primary and secondary osteoarthritis.
Teyi Pharmaceutical Group (002728.SZ) announced that its wholly-owned subsidiary Hainan Haili Pharmaceutical Co., Ltd. (referred to as "Haili Pharmaceutical") recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for glucosamine sulfate capsules. Glucosamine sulfate capsules are suitable for primary and secondary osteoarthritis.
Related Articles

Industrial: Market fluctuations intensify. How are various types of funds moving?

Chairman Zheng Jiachun increased his holding of CHOW TAI FOOK (01929) by 30,000 shares at a price of approximately HK$10.76 per share.

Chairman Pan Binze increases his holdings in TEXWINCA HOLD (00321) by 2.76 million shares at a price of approximately 1.21 Hong Kong dollars per share.
Industrial: Market fluctuations intensify. How are various types of funds moving?

Chairman Zheng Jiachun increased his holding of CHOW TAI FOOK (01929) by 30,000 shares at a price of approximately HK$10.76 per share.

Chairman Pan Binze increases his holdings in TEXWINCA HOLD (00321) by 2.76 million shares at a price of approximately 1.21 Hong Kong dollars per share.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


